Outcome of moderate-severe tricuspid regurgitation after pulmonary endarterectomy or balloon pulmonary angioplasty

Introduction and objectives: The management of persistent moderate-severe tricuspid regurgitation (TR) in patients with chronic thromboembolic pulmonary hypertension after treatment with pulmonary endarterectomy (PEA) or balloon pulmonary angioplasty (BPA) is not well defined. This study aimed to analyze the progression and predictors of significant persistent postintervention TR and its prognostic impact.Methods: This single-center observational study included 72 patients undergoing PEA and 20 who completed a BPA program with a previous diagnosis of chronic thromboembolic pulmonary hypertension and moderate-to-severe TR.Results: The postintervention prevalence of moderate-to-severe TR was 29%, with no difference between the PEA- or BPA-treated groups (30.6% vs 25% P = .78). Compared with patients with absent-mild postprocedure TR, those with persistent TR had higher mean pulmonary arterial pressure (40.2 +/- 1.9 vs 28.5 +/- 1.3 mmHg P < .001), pulmonary vascular resistance (472 [347-710] vs 282 [196-408] dyn.s/cm(5); P < .001), and right atrial area (23.0 [21-31] vs 16.0 [14.0-20.0] P < .001). The variables independently associated with persistent TR were pulmonary vascular resistance > 400 dyn.s/cm(5) and postprocedure right atrial area > 22 cm(2). No preintervention predictors were identified. The variables associated with increased 3-year mortality were residual TR and mean pulmonary arterial pressure > 30 mmHg.Conclusions: Residual moderate-to-severe TR following PEA-PBA was associated with persistently high afterload and unfavorable postintervention right chamber remodeling. Moderate-to-severe TR and residual pulmonary hypertension were associated with a worse 3-year prognosis.@ 2023 Sociedad Espantola de Cardiologia. Published by Elsevier Espanta, S.L.U. All rights reserved.